Fondazione Regione Toscana G. Monasterio, Pisa, Italy.
Pediatr Crit Care Med. 2013 Jun;14(5):508-17. doi: 10.1097/PCC.0b013e31828a89b9.
The aim of this study was to evaluate the diagnostic and prognostic accuracy of brain natriuretic peptide assay in neonates and children undergoing surgery for congenital heart disease.
Prospective, observational study.
Single center.
We enrolled 336 consecutive children (median age, 6 mo [range, 0-37 mo]) undergoing cardiac surgery (87 neonates; age, 7 d [5-12]; median, 25th-75th percentile; 24 infants and children; age, 11 mo [4-60]) and 436 healthy controls.
Brain natriuretic peptide was measured preoperatively, on every postoperative day in the ICU, and at discharge. Intubation time was the primary outcome.
Preoperative brain natriuretic peptide values in patients with congenital heart disease were higher than those in controls (p < 0.01). Brain natriuretic peptide had a good diagnostic accuracy in discriminating between patients with congenital heart disease and healthy controls with an area under the curve = 0.918 for neonates and area under the curve = 0.894 for older children. The best cutoff values, calculated by receiver operating characteristic analysis, were different for the two age subgroups with cutoff values of 363.5 ng/L for neonates and 23.5 ng/L for older children. At 24 hours after surgery, although brain natriuretic peptide decreased in neonates (baseline 2723 vs 1290 ng/L, p < 0.001), it increased in children (60 vs 365 ng/L at 24 hours, p < 0.001). Multivariable analysis identified the preoperative level of brain natriuretic peptide in infant/children and the difference in brain natriuretic peptide value (baseline 24 hours) in neonates, as independent predictors of intubation time. Furthermore, body surface area, Aristotle score, and cardiopulmonary bypass time had an independent significant effect on the endpoint in either group.
Baseline cardiac endocrine function and its response to surgical stress are dependent on age in neonates and children, undergoing cardiac surgery for congenital heart disease. Brain natriuretic peptide shows a good diagnostic and prognostic accuracy in this setting, with different features in either neonates or infants/children subsets.
本研究旨在评估脑利钠肽检测在先天性心脏病患儿手术中的诊断和预后准确性。
前瞻性观察性研究。
单中心。
我们纳入了 336 例连续接受心脏手术的患儿(中位年龄 6 个月[范围 0-37 个月])(87 例新生儿;年龄 7 天[5-12];中位值,25 至 75 百分位数;24 例婴儿和儿童;年龄 11 个月[4-60])和 436 例健康对照。
术前、ICU 内的每个术后日和出院时测量脑利钠肽。插管时间是主要结局。
先天性心脏病患儿的术前脑利钠肽值高于对照组(p < 0.01)。脑利钠肽在区分先天性心脏病患儿和健康对照组方面具有良好的诊断准确性,其曲线下面积(AUC)为新生儿 0.918,年龄较大的儿童 0.894。通过接受者操作特征(ROC)分析计算的最佳截断值因两个年龄亚组而异,新生儿的截断值为 363.5ng/L,年龄较大的儿童为 23.5ng/L。术后 24 小时,虽然新生儿脑利钠肽降低(基线 2723 与 1290ng/L,p < 0.001),但儿童升高(24 小时 60 与 365ng/L,p < 0.001)。多变量分析确定了婴儿/儿童的术前脑利钠肽水平和新生儿脑利钠肽值(24 小时基线)的差异是插管时间的独立预测因素。此外,体表面积、Aristotle 评分和体外循环时间在两组中均对终点有独立的显著影响。
在接受先天性心脏病心脏手术的新生儿和儿童中,基础心内分泌功能及其对手术应激的反应取决于年龄。脑利钠肽在此环境下具有良好的诊断和预后准确性,在新生儿或婴儿/儿童亚组中具有不同的特征。